COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
Euro Surveill
; 27(45)2022 11.
Article
in En
| MEDLINE
| ID: mdl-36367011
Key words
Full text:
1
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Year:
2022
Type:
Article